Xilio Therapeutics Inc. (XLO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Xilio Therapeutics Inc.

    NASDAQ: XLO · Real-Time Price · USD
    0.82
    0.02 (2.50%)
    At close: Oct 03, 2025, 3:59 PM
    0.82
    0.86%
    After-hours: Oct 03, 2025, 07:46 PM EDT

    Xilio Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 55.29M 44.7M 120.39M 198.05M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 1.78M n/a 1.56M 1.55M
    Other Long-Term Assets
    		 n/a 1.6M 267K 1.95M
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 4.94M 3.42M 4.11M 4.46M
    Total Current Assets
    		 60.23M 48.13M 124.5M 202.52M
    Property-Plant & Equipment
    		 9.06M 11.2M 12.84M 13.6M
    Goodwill & Intangibles
    		 n/a n/a n/a -5.09M
    Total Long-Term Assets
    		 10.84M 12.8M 14.67M 15.54M
    Total Assets
    		 71.08M 60.93M 139.16M 218.06M
    Account Payables
    		 2.57M 1.05M 3.13M 3.14M
    Deferred Revenue
    		 13.52M n/a n/a 8.75M
    Short-Term Debt
    		 n/a 3.31M 6.67M n/a
    Other Current Liabilities
    		 4.21M 6.9M 82K 82K
    Total Current Liabilities
    		 27.26M 15.96M 21.12M 12.78M
    Long-Term Debt
    		 n/a n/a 3.17M 9.63M
    Other Long-Term Liabilities
    		 n/a n/a 45K 118K
    Total Long-Term Liabilities
    		 26.22M 8.14M 12.4M 19.85M
    Total Liabilities
    		 53.48M 24.1M 33.52M 32.63M
    Total Debt
    		 8.14M 11.46M 19.94M 20.54M
    Book Value
    		 17.6M 36.83M 105.65M 185.43M
    Book Value Per Share
    		 0.33 1.34 3.86 6.78
    Common Stock
    		 5K 3K 3K 3K
    Retained Earnings
    		 -383.75M -325.51M -249.11M -160.89M
    Comprehensive Income
    		 n/a n/a n/a -218.06M
    Shareholders Equity
    		 17.6M 36.83M 105.65M 185.43M
    Total Investments
    		 1.78M 1.59M 1.56M 1.55M

    Add to Watchlist